S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

STAAR Surgical Stock Forecast, Price & News

+1.26 (+1.78%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
283,921 shs
Average Volume
498,051 shs
Market Capitalization
$3.45 billion
P/E Ratio
Dividend Yield
Price Target

STAAR Surgical Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.83 Rating Score
40.8% Upside
$101.67 Price Target
Short Interest
6.96% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.46mentions of STAAR Surgical in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$2.01 M Sold Last Quarter
Proj. Earnings Growth
From $0.65 to $1.12 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.48 out of 5 stars

Medical Sector

97th out of 1,428 stocks

Ophthalmic Goods Industry

3rd out of 7 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAAR Surgical logo

About STAAR Surgical (NASDAQ:STAA)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA Stock News Headlines

Should You Buy Stocks When the Market Crashes?
STAAR Surgical Tops Q1 EPS by 11c
STAAR Surgical Q1 2022 Earnings Preview
Why STAAR Surgical Stock Dropped 12% This Week
See More Headlines

Industry, Sector and Symbol

Ophthalmic goods
Health Care Supplies
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
6 Analysts


Net Income
$24.50 million
Pretax Margin


Sales & Book Value

Annual Sales
$230.47 million
Cash Flow
$0.65 per share
Book Value
$5.43 per share


Free Float
Market Cap
$3.45 billion

Social Links

STAAR Surgical Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STAAR Surgical stock.
View analyst ratings for STAAR Surgical
or view top-rated stocks.

What is STAAR Surgical's stock price forecast for 2022?

6 brokerages have issued twelve-month price targets for STAAR Surgical's stock. Their STAA stock forecasts range from $87.00 to $150.00. On average, they predict STAAR Surgical's share price to reach $101.67 in the next twelve months. This suggests a possible upside of 40.8% from the stock's current price.
View analysts' price targets for STAAR Surgical
or view top-rated stocks among Wall Street analysts.

How has STAAR Surgical's stock price performed in 2022?

STAAR Surgical's stock was trading at $91.30 at the beginning of 2022. Since then, STAA shares have decreased by 20.9% and is now trading at $72.19.
View the best growth stocks for 2022 here

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for STAAR Surgical

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) released its quarterly earnings data on Wednesday, May, 4th. The medical instruments supplier reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.11. The medical instruments supplier had revenue of $63.20 million for the quarter, compared to analyst estimates of $60.53 million. STAAR Surgical had a trailing twelve-month return on equity of 12.78% and a net margin of 11.98%. The business's revenue was up 24.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 EPS.
View STAAR Surgical's earnings history

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $295.00 million-$295.00 million, compared to the consensus revenue estimate of $295.37 million.

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $72.19.

How much money does STAAR Surgical make?

STAAR Surgical (NASDAQ:STAA) has a market capitalization of $3.45 billion and generates $230.47 million in revenue each year. The medical instruments supplier earns $24.50 million in net income (profit) each year or $0.579990 on an earnings per share basis.

How many employees does STAAR Surgical have?

STAAR Surgical employs 692 workers across the globe.

Does STAAR Surgical have any subsidiaries?

The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More

When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for STAAR Surgical is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.